These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38760935)

  • 1. NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities.
    Fiadeiro MB; Diogo JC; Silva AA; Kim YS; Cristóvão AC
    Antioxid Redox Signal; 2024 Sep; 41(7-9):522-541. PubMed ID: 38760935
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.
    Tarafdar A; Pula G
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights of NADPH oxidases and its pathological consequences.
    Waghela BN; Vaidya FU; Agrawal Y; Santra MK; Mishra V; Pathak C
    Cell Biochem Funct; 2021 Mar; 39(2):218-234. PubMed ID: 32975319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights on NOX enzymes in the central nervous system.
    Nayernia Z; Jaquet V; Krause KH
    Antioxid Redox Signal; 2014 Jun; 20(17):2815-37. PubMed ID: 24206089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington's Disease?
    Villegas L; Nørremølle A; Freude K; Vilhardt F
    Front Aging Neurosci; 2021; 13():736734. PubMed ID: 34803655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
    Sorce S; Stocker R; Seredenina T; Holmdahl R; Aguzzi A; Chio A; Depaulis A; Heitz F; Olofsson P; Olsson T; Duveau V; Sanoudou D; Skosgater S; Vlahou A; Wasquel D; Krause KH; Jaquet V
    Free Radic Biol Med; 2017 Nov; 112():387-396. PubMed ID: 28811143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Role of Reactive Oxygen Species-Generating Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Gastrointestinal Inflammation and Therapeutic Perspectives.
    Dang PM; Rolas L; El-Benna J
    Antioxid Redox Signal; 2020 Aug; 33(5):354-373. PubMed ID: 31968991
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA Targeting Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Cancer.
    Kushwaha PP; Gupta S; Singh AK; Prajapati KS; Shuaib M; Kumar S
    Antioxid Redox Signal; 2020 Feb; 32(5):267-284. PubMed ID: 31656079
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
    Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
    Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
    [No Abstract]   [Full Text] [Related]  

  • 10. NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases.
    Fang J; Sheng R; Qin ZH
    Antioxid Redox Signal; 2021 Oct; 35(12):951-973. PubMed ID: 34293949
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
    Altenhöfer S; Radermacher KA; Kleikers PW; Wingler K; Schmidt HH
    Antioxid Redox Signal; 2015 Aug; 23(5):406-27. PubMed ID: 24383718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.
    Kahles T; Brandes RP
    Antioxid Redox Signal; 2013 Apr; 18(12):1400-17. PubMed ID: 22746273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology.
    DeVallance E; Li Y; Jurczak MJ; Cifuentes-Pagano E; Pagano PJ
    Antioxid Redox Signal; 2019 Oct; 31(10):687-709. PubMed ID: 31250671
    [No Abstract]   [Full Text] [Related]  

  • 16. NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease.
    Rastogi R; Geng X; Li F; Ding Y
    Front Cell Neurosci; 2016; 10():301. PubMed ID: 28119569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nox, Nox, Are You There? The Role of NADPH Oxidases in the Peripheral Nervous System.
    Eid SA; Savelieff MG; Eid AA; Feldman EL
    Antioxid Redox Signal; 2022 Sep; 37(7-9):613-630. PubMed ID: 34861780
    [No Abstract]   [Full Text] [Related]  

  • 18. Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences.
    Brandes RP; Weissmann N; Schröder K
    Antioxid Redox Signal; 2014 Feb; 20(6):887-98. PubMed ID: 23682993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide Adenosine Dinucleotide Phosphate Oxidase-Mediated Signaling in Cardiac Remodeling.
    Visnagri A; Oexner RR; Kmiotek-Wasylewska K; Zhang M; Zoccarato A; Shah AM
    Antioxid Redox Signal; 2023 Feb; 38(4-6):371-387. PubMed ID: 36656669
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of NOX inhibitors in neurodegenerative diseases.
    Barua S; Kim JY; Yenari MA; Lee JE
    IBRO Rep; 2019 Dec; 7():59-69. PubMed ID: 31463415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.